BAH and BPI plan to merge

17.12.2019 10:37

In intensive exploratory discussions, the boards of the Federal Association of Drug Manufacturers (BAH) and the Federal Association of the Pharmaceutical Industry (BPI) discussed the possibilities of future collaboration. As a result, the boards of both associations are proposing a merger to the member companies. The resulting association would represent more than 90 percent of the pharmaceutical companies operating in Germany.

According to the two associations, by optimally complementing the service portfolios and bundling resources, the needs and requirements of member companies could be better perceived by an even stronger representation of interests.

In view of the health policy and economic challenges at both national and international level, a joint association offers real added value in the perspective of both boards.

In the coming months, the legal and organizational requirements for the new association will be prepared and presented to the members' and delegates' meetings of BAH and BPI in summer 2020 for voting.